Table 2. Attainment of guideline LDL-C targets by patient disease group.
| Variables | Total (N=858,509) |
Preexisting CeVD (N=251,176) | Preexisting CVD (N=44,158) | Preexisting concomitant CeVD and CVD (N=33,070) | No history of CeVD/CVD (N=530,105) | P value |
|---|---|---|---|---|---|---|
| LDL-C targets | ||||||
| <2.6 mmol/L | 397,596 (46.3) | 124,927 (49.7) | 22,193 (50.3) | 17,375 (52.5) | 233,101 (44.0) | <0.001 |
| <1.8 mmol/L | 128,177 (14.9) | 45,008 (17.9) | 7,676 (17.4) | 6,856 (20.7) | 68,637 (12.9) | <0.001 |
| <1.4 mmol/L | 55,275 (6.4) | 19,932 (7.9) | 3,349 (7.6) | 3,030 (9.2) | 28,964 (5.5) | <0.001 |
| Discharged on statins | 766,681 (89.3) | 222,328 (88.5) | 39,440 (89.3) | 29,414 (88.9) | 475,499 (89.7) | <0.001 |
CeVD, cerebrovascular disease; CVD, cardiovascular disease; LDL-C, low-density lipoprotein cholesterol.